Literature DB >> 18848593

Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.

Karoline Droebner1, Emanuel Haasbach, Cordula Fuchs, Andreas O Weinzierl, Stefan Stevanovic, Mathias Büttner, Oliver Planz.   

Abstract

A H5N2 low pathogenic avian influenza virus (LPAIV) was isolated from a natural reservoir in Bavaria during a routine screen and was used as a vaccine strain to scrutinize the immune response involved in cross-protection after challenge infection with a H5N1 highly pathogenic avian influenza virus (HPAIV). The challenge virus was also isolated from a natural reservoir in Bavaria. Wild type, antibody deficient (muMT), CD4(-/-) and CD8(-/-) mice were infected with the apathogenic H5N2 vaccine strain and challenge infection with a 100-fold MLD(50) of the H5N1 strain was performed 80 days later. While 100% of the wild type and 100% of the CD8(-/-) mice stayed healthy, only 50% of the CD4(-/-) and none of the antibody deficient mice were protected. These results support the view that the humoral immune response and to certain extends the CD4(+) T helper cells are a prerequisite for cross-protective immunity against H5 influenza virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848593     DOI: 10.1016/j.vaccine.2008.09.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  H5N1 vaccines in humans.

Authors:  Mariana Baz; Catherine J Luke; Xing Cheng; Hong Jin; Kanta Subbarao
Journal:  Virus Res       Date:  2013-05-28       Impact factor: 3.303

2.  M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.

Authors:  D G Eliasson; A Omokanye; K Schön; U A Wenzel; V Bernasconi; M Bemark; A Kolpe; K El Bakkouri; T Ysenbaert; L Deng; W Fiers; X Saelens; N Lycke
Journal:  Mucosal Immunol       Date:  2017-03-01       Impact factor: 7.313

3.  Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.

Authors:  Maria E Lorenzo; Andrea Hodgson; Dionne P Robinson; Jenifer B Kaplan; Andrew Pekosz; Sabra L Klein
Journal:  Vaccine       Date:  2011-10-06       Impact factor: 3.641

4.  Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

Authors:  Lucy A Perrone; Attiya Ahmad; Vic Veguilla; Xiuhua Lu; Gale Smith; Jacqueline M Katz; Peter Pushko; Terrence M Tumpey
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

5.  Pandemic influenza vaccines - the challenges.

Authors:  Lars R Haaheim; Abdullah S Madhun; Rebecca Cox
Journal:  Viruses       Date:  2009-12-03       Impact factor: 5.048

Review 6.  Immune responses to infection with H5N1 influenza virus.

Authors:  Guus F Rimmelzwaan; Jacqueline M Katz
Journal:  Virus Res       Date:  2013-06-02       Impact factor: 3.303

7.  Exposure to a low pathogenic A/H7N2 virus in chickens protects against highly pathogenic A/H7N1 virus but not against subsequent infection with A/H5N1.

Authors:  Júlia Vergara-Alert; Ana Moreno; Juliana G Zabala; Kateri Bertran; Taiana P Costa; Iván Cordón; Raquel Rivas; Natàlia Majó; Núria Busquets; Paolo Cordioli; Fernando Rodriguez; Ayub Darji
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

8.  Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection.

Authors:  Hadi Maazi; Abinav K Singh; Anneliese O Speak; Vincent Lombardi; Jonathan Lam; Bryant Khoo; Kyung Soo Inn; Arlene H Sharpe; Jae U Jung; Omid Akbari
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

9.  Construction of a chimeric secretory IgA and its neutralization activity against avian influenza virus H5N1.

Authors:  Cun Li; Xiaoping An; Azeem Mehmood Butt; Baozhong Zhang; Zhiyi Zhang; Xiaona Wang; Yong Huang; Wenhui Zhang; Bo Zhang; Zhiqiang Mi; Yigang Tong
Journal:  J Immunol Res       Date:  2014-02-13       Impact factor: 4.818

10.  Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.

Authors:  Christophe Barnier-Quer; Abdelrahman Elsharkawy; Stefan Romeijn; Alexander Kros; Wim Jiskoot
Journal:  Pharmaceutics       Date:  2013-07-25       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.